Optimizing MIGS for Practice and Center Success - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Optimizing MIGS for Practice and Center Success

The key is execution, understanding the clinical landscape, controlling device cost, engineering the intraoperative workflow, and scheduling/staffing with intention.

  • By

  • Mitchell C. Shultz, MD

  • July 1, 2026

  • 9 min

Share

  • 1

    Minimally invasive glaucoma surgery (MIGS) is essential for enhancing clinical outcomes and operational efficiency in ambulatory surgical centers (ASCs).

  • 2

    MIGS complements high-volume cataract surgery and can be performed with minimal disruption, often taking only 3-8 additional minutes.

  • 3

    The iStent Infinite and Hydrus Microstent are FDA-cleared devices for treating refractory primary open-angle glaucoma in adults.

  • 4

    Operational efficiency in ASCs is crucial for profitability, and MIGS can be integrated without significantly affecting surgical schedules.

  • 5

    Sustained-release drug delivery systems like iDose TR and Durysta provide long-term intraocular pressure control and address patient compliance.

Original Source(s)

Optimizing MIGS for Practice and Center Success

  • by Mitchell C. Shultz, MD

  • July 1, 2026

Related Content

Vitrectomy Linked to Higher CME Risk

Large US database study suggests previous pars plana vitrectomy may substantially increase likelihood of pseudophakic cystoid macular edema

  • August 26, 2026

  • 3 min
Transfer learning and vision transformer for the automatic diagnosis of cataracts in ophthalmological images

Expanding visual horizons: comparative outcomes of bilateral implantation of an extended depth-of-focus versus enhanced and standard monofocal intraocular lenses